Verastem | VSTM - 营业利润

金融业

USD

USD 246.44M

现金及等价物

USD 204.99M

USD 2.89M

USD 223.41M

USD 72.27M

USD 66.79M

股息收益率

0

USD -41.48M

USD -21.3M

73

EPS每股收益

USD -0.48

股本和储备

USD 57.2M

USD 14.64M

债务利息支出

USD 415K

USD 831K

USD 81.33M

USD 146.7M

USD -32.92M

USD 59.01M

USD -41.48M

普通股股本

USD 77.74M

USD -32.92M

USD 17.54M

销售和管理费用

USD 24.44M

USD 0

贸易债权人

USD 12.45M

应收帐款人

USD 9.01M

	营业利润	更改		日
AbbVie	USD 6.72B		1.99B	2026-06
Alaunos Therapeutics	USD -1.01M		175K	2026-03
AstraZeneca	USD 3.16B		3.95B	2026-06
Curis	USD -7.88M		4.63M	2025-12
Cytokinetics	USD -181.23M		2.86M	2026-03
Gilead Sciences	USD 2.68B		284M	2026-03
Incyte	USD 700.4M		376.22M	2026-06
Laboratory Of America	USD 456.7M		46.6M	2026-06
Novartis	USD 4.75B		515M	2026-06
Pfizer	USD 4.99B		340M	2026-03
Roche Holding	CHF 11.46B		1.91B	2026-06
TG Therapeutics	USD 34.8M		15.7M	2026-03
Verastem	USD -41.48M		23.2M	2025-12